Target Information
Target General Infomation | |||||
---|---|---|---|---|---|
Target ID |
T67952
|
||||
Former ID |
TTDR00174
|
||||
Target Name |
Potassium channel
|
||||
Target Type |
Successful
|
||||
Disease | Alopecia [ICD9: 704.09; ICD10: L65.9] | ||||
Arteriosclerosis [ICD9: 440; ICD10: I70] | |||||
Atrial fibrillation; Atrial flutter [ICD9: 427.31, 487, 488; ICD10: I48, J10, J11] | |||||
Atrial fibrillation [ICD9: 272, 427.31; ICD10: E78, I48] | |||||
Arrhythmia [ICD9: 427; ICD10: I47-I49] | |||||
Angina pectoris [ICD9: 413; ICD10: I20] | |||||
Asthma [ICD10: J45] | |||||
Cerebrovascular ischaemia [ICD9: 434.91; ICD10: I61-I63] | |||||
Chronic obstructive pulmonary disease [ICD9: 490-492, 494-496; ICD10: J40-J44, J47] | |||||
Cardiac arrhythmias [ICD9: 427; ICD10: I47-I49] | |||||
Diabetes [ICD9: 253.5, 588.1; ICD10: E23.2, N25.1] | |||||
High blood pressure [ICD9: 401; ICD10: I10-I16] | |||||
Hypertension [ICD9: 401; ICD10: I10-I16] | |||||
Heart arrhythmia [ICD10: I47-I49] | |||||
Multiple scierosis [ICD9: 340; ICD10: G35] | |||||
Maintenance of normal sinus rhythm [ICD9: 427; ICD10: I46-I49] | |||||
Major depressive disorder [ICD9: 296.2, 296.3, 710.0; ICD10: F32, F33, M32] | |||||
Nerve injury [ICD10: T14.4] | |||||
Overactive bladder disorder [ICD9: 188, 596.51; ICD10: C67, N32.81] | |||||
Obstructive sleep apnea [ICD9: 327.23, 780.57; ICD10: G47.3] | |||||
Ocular hypertension [ICD9: 365.04; ICD10: H40.0] | |||||
Rhinitis [ICD9: 472.0, 477; ICD10: J00, J30, J31.0] | |||||
Solid tumours [ICD9: 140-199, 210-229; ICD10: C00-D48] | |||||
Tachyarrhythmias [ICD9: 427, 785.0; ICD10: I47-I49, R00.0] | |||||
Urinary incontinence [ICD9: 788.3; ICD10: N39.3, N39.4, R32] | |||||
Unspecified [ICD code not available] | |||||
Drugs and Mode of Action | |||||
Drug(s) | Amiodarone | Drug Info | Approved | Tachyarrhythmias | [536095], [539657] |
Dalfampridine | Drug Info | Approved | Multiple scierosis | [531351] | |
Diazoxide | Drug Info | Approved | Hypertension | [538482], [539538] | |
Dofetilide | Drug Info | Approved | Maintenance of normal sinus rhythm | [536095], [539681] | |
Ibutilide | Drug Info | Approved | Atrial fibrillation | [536095], [542214] | |
Minoxidil | Drug Info | Approved | Hypertension | [467589], [538235] | |
Nateglinide | Drug Info | Approved | Diabetes | [536361], [541914] | |
Pinacidil | Drug Info | Approved | High blood pressure | [538525], [539542] | |
Andolast | Drug Info | Phase 3 | Rhinitis | [545161] | |
Azimilide | Drug Info | Phase 3 | Atrial fibrillation | [536095], [539666] | |
AZD-7009 | Drug Info | Phase 2 | Atrial fibrillation | [521760] | |
Bimakalim | Drug Info | Phase 2 | Angina pectoris | [527063] | |
HBI-3000 | Drug Info | Phase 2 | Heart arrhythmia | [523241] | |
MSH-1001 | Drug Info | Phase 2 | Ocular hypertension | [548251] | |
RP-49356 | Drug Info | Phase 2 | Hypertension | [544588] | |
YM-934 | Drug Info | Phase 2 | Angina pectoris | [544960] | |
AVE0118 | Drug Info | Phase 1 | Obstructive sleep apnea | [547751] | |
CLP-1004 | Drug Info | Phase 1 | Hypertension | [549413] | |
Iptakalim hydrochloride | Drug Info | Phase 1 | Hypertension | [531817] | |
Nibentan | Drug Info | Phase 1 | Cardiac arrhythmias | [534342] | |
NS-8 | Drug Info | Phase 1 | Urinary incontinence | [551445] | |
UK-66914 | Drug Info | Phase 1 | Cardiac arrhythmias | [544558] | |
Levcromakalim | Drug Info | Discontinued in Preregistration | Chronic obstructive pulmonary disease | [544517] | |
Acecainide | Drug Info | Discontinued in Phase 3 | Solid tumours | [544619] | |
Alinidine | Drug Info | Discontinued in Phase 3 | Angina pectoris | [544609] | |
Almokalant | Drug Info | Discontinued in Phase 3 | Cardiac arrhythmias | [544820] | |
BMS-204352 | Drug Info | Discontinued in Phase 3 | Nerve injury | [539459], [546835] | |
Ambasilide | Drug Info | Discontinued in Phase 2 | Cardiac arrhythmias | [544977] | |
BMS-180448 | Drug Info | Discontinued in Phase 2 | Angina pectoris | [545720] | |
BRL-32872A | Drug Info | Discontinued in Phase 2 | Cardiac arrhythmias | [544642] | |
BRL-55834 | Drug Info | Discontinued in Phase 2 | Chronic obstructive pulmonary disease | [544932] | |
E-4031 | Drug Info | Discontinued in Phase 2 | Cardiac arrhythmias | [539682], [544654] | |
JTV-506 | Drug Info | Discontinued in Phase 2 | Angina pectoris | [546047] | |
KCO-912 | Drug Info | Discontinued in Phase 2 | Chronic obstructive pulmonary disease | [547581] | |
KW-7158 | Drug Info | Discontinued in Phase 2 | Urinary incontinence | [547139] | |
P-1075 | Drug Info | Discontinued in Phase 2 | Hypertension | [544865] | |
Risotilide | Drug Info | Discontinued in Phase 2 | Heart arrhythmia | [545179] | |
Y-27152 | Drug Info | Discontinued in Phase 2 | Angina pectoris | [544925] | |
ZD-0947 | Drug Info | Discontinued in Phase 2 | Overactive bladder disorder | [546657] | |
ZD-6169 | Drug Info | Discontinued in Phase 2 | Urinary incontinence | [546120] | |
Emakalim | Drug Info | Discontinued in Phase 1 | Angina pectoris | [544976] | |
KR-30450 | Drug Info | Discontinued in Phase 1 | Hypertension | [545884] | |
NTC-801 | Drug Info | Discontinued in Phase 1 | Atrial fibrillation; Atrial flutter | [548263] | |
Rilmakalim | Drug Info | Discontinued in Phase 1 | Chronic obstructive pulmonary disease | [544828] | |
Ro-31-6930 | Drug Info | Discontinued in Phase 1 | Hypertension | [544524] | |
SDZ-PCO-400 | Drug Info | Discontinued in Phase 1 | Asthma | [544952] | |
SR-47063 | Drug Info | Discontinued in Phase 1 | Cardiac arrhythmias | [545164] | |
Symakalim | Drug Info | Discontinued in Phase 1 | Hypertension | [545492] | |
AL-0671 | Drug Info | Terminated | Arteriosclerosis | [545871] | |
Antiarrhythmics | Drug Info | Terminated | Heart arrhythmia | [547259] | |
AWD-23-111 | Drug Info | Terminated | Heart arrhythmia | [545974] | |
E-4080 | Drug Info | Terminated | Angina pectoris | [544975] | |
ICI-181037 | Drug Info | Terminated | Heart arrhythmia | [544804] | |
KC-399 | Drug Info | Terminated | Alopecia | [545323] | |
Ki-1769 | Drug Info | Terminated | Hypertension | [545263] | |
NS-004 | Drug Info | Terminated | Hypertension | [467608], [534399] | |
NS-1546 | Drug Info | Terminated | Major depressive disorder | [546073] | |
NS-1608 | Drug Info | Terminated | Cerebrovascular ischaemia | [546099] | |
Org-20781 | Drug Info | Terminated | Heart arrhythmia | [545460] | |
RP-66784 | Drug Info | Terminated | Angina pectoris | [545485] | |
S-1389 | Drug Info | Terminated | Heart arrhythmia | [544580] | |
SB-237376 | Drug Info | Terminated | Arrhythmia | [526551] | |
TCV-295 | Drug Info | Terminated | Hypertension | [545250] | |
TERIKALANT | Drug Info | Terminated | Cardiac arrhythmias | [544992] | |
UR-8225 | Drug Info | Terminated | Asthma | [545251] | |
UR-8308 | Drug Info | Terminated | Asthma | [545904] | |
UR-8328 | Drug Info | Terminated | Asthma | [545902] | |
WAY-123223 | Drug Info | Terminated | Heart arrhythmia | [544991] | |
YM-099 | Drug Info | Terminated | Hypertension | [545252] | |
Opener | Acecainide | Drug Info | [528400] | ||
AL-0671 | Drug Info | [533844] | |||
Andolast | Drug Info | [529468] | |||
AWD-23-111 | Drug Info | [534834] | |||
BRL-55834 | Drug Info | [534028] | |||
E-4080 | Drug Info | [528942] | |||
Emakalim | Drug Info | [533839] | |||
ICI-181037 | Drug Info | [529231] | |||
Iptakalim hydrochloride | Drug Info | [531635], [531817] | |||
JTV-506 | Drug Info | [525479] | |||
KC-399 | Drug Info | [533609] | |||
Ki-1769 | Drug Info | [533948] | |||
KR-30450 | Drug Info | [531635], [534585] | |||
MSH-1001 | Drug Info | [530084] | |||
NS-004 | Drug Info | [534399] | |||
NS-1546 | Drug Info | [546074] | |||
NS-1608 | Drug Info | [534284] | |||
Org-20781 | Drug Info | [545461] | |||
P-1075 | Drug Info | [531373] | |||
Rilmakalim | Drug Info | [527119] | |||
Risotilide | Drug Info | [528009] | |||
Ro-31-6930 | Drug Info | [532406] | |||
RP-49356 | Drug Info | [531486] | |||
RP-66784 | Drug Info | [534059] | |||
S-1389 | Drug Info | [544581] | |||
SDZ-PCO-400 | Drug Info | [526806] | |||
SR-47063 | Drug Info | [525839] | |||
TCV-295 | Drug Info | [531635], [533790] | |||
UR-8225 | Drug Info | [533977] | |||
UR-8308 | Drug Info | [545905] | |||
UR-8328 | Drug Info | [545903] | |||
WAY-123223 | Drug Info | [530230] | |||
Y-27152 | Drug Info | [534178] | |||
YM-099 | Drug Info | [533769] | |||
ZD-0947 | Drug Info | [526383] | |||
ZD-6169 | Drug Info | [526383] | |||
Blocker | Alinidine | Drug Info | [533559] | ||
Ambasilide | Drug Info | [525482] | |||
HBI-3000 | Drug Info | [531239] | |||
Nibentan | Drug Info | [527507], [531635] | |||
Trecetilide fumarate | Drug Info | [527182], [531635] | |||
UK-66914 | Drug Info | [528531] | |||
YM-934 | Drug Info | [533616] | |||
Modulator | Almokalant | Drug Info | |||
Amiodarone | Drug Info | [556264] | |||
AVE0118 | Drug Info | ||||
AZD-7009 | Drug Info | [532667] | |||
Azimilide | Drug Info | ||||
BMS-204352 | Drug Info | [1572591] | |||
BRL-32872A | Drug Info | ||||
CGS-7181 | Drug Info | ||||
Dalfampridine | Drug Info | [531351] | |||
Diazoxide | Drug Info | [556264] | |||
Dofetilide | Drug Info | [556264] | |||
E-4031 | Drug Info | ||||
HMR1883 | Drug Info | ||||
Ibutilide | Drug Info | [556264] | |||
JTV 519 | Drug Info | ||||
L 691121 | Drug Info | ||||
Levcromakalim | Drug Info | ||||
Minoxidil | Drug Info | [556264] | |||
MJ-451 | Drug Info | ||||
Nateglinide | Drug Info | [556264] | |||
Pinacidil | Drug Info | [556264] | |||
RP-66471 | Drug Info | ||||
SB-237376 | Drug Info | [526551] | |||
TERIKALANT | Drug Info | ||||
WAY-125971 | Drug Info | [530230] | |||
Y-26763 | Drug Info | ||||
Inhibitor | Antiarrhythmics | Drug Info | [547258] | ||
NTC-801 | Drug Info | [532768] | |||
Agonist | Bimakalim | Drug Info | [527063] | ||
BMS-180448 | Drug Info | [534264] | |||
KCO-912 | Drug Info | [526289] | |||
KW-7158 | Drug Info | [526989] | |||
NS-8 | Drug Info | [532744] | |||
Symakalim | Drug Info | [534618] | |||
Binder | CLP-1004 | Drug Info | [549414] | ||
References | |||||
Ref 467589 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4254). | ||||
Ref 467608 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4271). | ||||
Ref 521760 | ClinicalTrials.gov (NCT00255281) Efficacy and Safety of AZD7009 in the Treatment of Atrial Fibrillation. U.S. National Institutes of Health. | ||||
Ref 523241 | ClinicalTrials.gov (NCT01235156) Efficacy and Safety of Sulcardine Sulfate Tablets in Patients With Premature Ventricular Contractions. U.S. National Institutes of Health. | ||||
Ref 526551 | Electrophysiologic effects of SB-237376: a new antiarrhythmic compound with dual potassium and calcium channel blocking action. J Cardiovasc Pharmacol. 2003 Mar;41(3):414-21. | ||||
Ref 527063 | Lack of anti-ischemic efficacy of the potassium channel opener bimakalim in patients with stable angina pectoris. Cardiovasc Drugs Ther. 2004 Jan;18(1):37-46. | ||||
Ref 531817 | Iptakalim: A novel multi-utility potassium channel opener. J Pharmacol Pharmacother. 2012 Jan;3(1):12-4. | ||||
Ref 534342 | Electrophysiologic effects of nibentan (HE-11) on canine cardiac tissue. J Pharmacol Exp Ther. 1997 Mar;280(3):1137-46. | ||||
Ref 534399 | Effects of K+ channel inhibitors and antagonists on NS-004 evoked relaxations in guinea-pig isolated trachea. Fundam Clin Pharmacol. 1997;11(1):78-82. | ||||
Ref 536095 | New antiarrhythmic agents for atrial fibrillation and atrial flutter. Expert Opin Emerg Drugs. 2005 May;10(2):311-22. | ||||
Ref 536361 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. | ||||
Ref 538235 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 071344. | ||||
Ref 538482 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 016996. | ||||
Ref 538525 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 019456. | ||||
Ref 539459 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2307). | ||||
Ref 539538 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2409). | ||||
Ref 539542 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2412). | ||||
Ref 539657 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2566). | ||||
Ref 539666 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2588). | ||||
Ref 539681 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2604). | ||||
Ref 539682 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2605). | ||||
Ref 541914 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6833). | ||||
Ref 542214 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7200). | ||||
Ref 544517 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000036) | ||||
Ref 544524 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000054) | ||||
Ref 544558 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000131) | ||||
Ref 544580 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000214) | ||||
Ref 544588 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000232) | ||||
Ref 544609 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000286) | ||||
Ref 544619 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000315) | ||||
Ref 544642 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000403) | ||||
Ref 544654 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000439) | ||||
Ref 544804 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001161) | ||||
Ref 544820 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001219) | ||||
Ref 544828 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001252) | ||||
Ref 544865 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001364) | ||||
Ref 544925 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001561) | ||||
Ref 544932 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001581) | ||||
Ref 544952 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001697) | ||||
Ref 544960 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001721) | ||||
Ref 544975 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001760) | ||||
Ref 544976 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001761) | ||||
Ref 544977 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001764) | ||||
Ref 544991 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001818) | ||||
Ref 544992 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001820) | ||||
Ref 545161 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002324) | ||||
Ref 545164 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002328) | ||||
Ref 545179 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002381) | ||||
Ref 545250 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002578) | ||||
Ref 545251 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002580) | ||||
Ref 545252 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002582) | ||||
Ref 545263 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002625) | ||||
Ref 545323 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002834) | ||||
Ref 545460 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003350) | ||||
Ref 545485 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003444) | ||||
Ref 545492 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003464) | ||||
Ref 545720 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004365) | ||||
Ref 545871 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005136) | ||||
Ref 545884 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005207) | ||||
Ref 545902 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005293) | ||||
Ref 545904 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005294) | ||||
Ref 545974 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005585) | ||||
Ref 546047 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006044) | ||||
Ref 546073 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006187) | ||||
Ref 546099 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006351) | ||||
Ref 546120 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006442) | ||||
Ref 546657 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009535) | ||||
Ref 546835 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010536) | ||||
Ref 547139 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800013319) | ||||
Ref 547259 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014534) | ||||
Ref 547581 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017535) | ||||
Ref 547751 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019047) | ||||
Ref 548251 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023795) | ||||
Ref 548263 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023917) | ||||
Ref 525479 | Effects of the new potassium channel opener JTV-506 on coronary vessels in vitro and in vivo. Arzneimittelforschung. 1999 Mar;49(3):199-206. | ||||
Ref 525482 | Ambasilide prolongs the action potential and blocks multiple potassium currents in human atrium. J Cardiovasc Pharmacol. 1999 May;33(5):762-71. | ||||
Ref 525839 | Vasorelaxant effects of the potassium channel opener SR 47063 on the isolated human saphenous vein and rat aorta. Braz J Med Biol Res. 2000 Aug;33(8):961-6. | ||||
Ref 526289 | KCO912: a potent and selective opener of ATP-dependent potassium (K(ATP)) channels which suppresses airways hyperreactivity at doses devoid of cardiovascular effects. Naunyn Schmiedebergs Arch Pharmacol. 2002 Mar;365(3):220-30. Epub 2002 Jan 23. | ||||
Ref 526383 | Effects of ZD6169 and ZD0947, 2 potassium adenosine triphosphate channel openers, on bladder function of spinalized rats. J Urol. 2002 Aug;168(2):837-42. | ||||
Ref 526551 | Electrophysiologic effects of SB-237376: a new antiarrhythmic compound with dual potassium and calcium channel blocking action. J Cardiovasc Pharmacol. 2003 Mar;41(3):414-21. | ||||
Ref 526806 | Effects of a potassium channel opener (SDZ PCO 400) on guinea-pig and human pulmonary airways. Br J Pharmacol. 1992 Jun;106(2):423-9. | ||||
Ref 526989 | KW-7158 [(2S)-(+)-3,3,3-trifluoro-2-hydroxy-2-methyl-N-(5,5,10-trioxo-4,10-dihydrothieno[3,2-c][1]benzothiepin-9-yl)propanamide] enhances A-type K+ currents in neurons of the dorsal root ganglion of the adult rat. J Pharmacol Exp Ther. 2004 Jul;310(1):159-68. Epub 2004 Mar 9. | ||||
Ref 527063 | Lack of anti-ischemic efficacy of the potassium channel opener bimakalim in patients with stable angina pectoris. Cardiovasc Drugs Ther. 2004 Jan;18(1):37-46. | ||||
Ref 527119 | Hypotonic stress increases efficacy of rilmakalim, but not pinacidil, to activate ATP-sensitive K(+) current in guinea pig ventricular myocytes. J Pharmacol Sci. 2004 Jun;95(2):189-95. | ||||
Ref 527182 | IKr channel blockers: novel antiarrhythmic agents. Curr Med Chem Cardiovasc Hematol Agents. 2003 Oct;1(3):203-23. | ||||
Ref 527507 | Nibentan -- a drug for pharmacological cardioversion of persistent atrial fibrillation. Kardiologiia. 2005;45(3):19-23. | ||||
Ref 528009 | Electrophysiological effects of left ventricular hypertrophy. Effect of calcium and potassium channel blockade. Circulation. 1991 Jun;83(6):2067-75. | ||||
Ref 528400 | Acecainide (N-acetylprocainamide). A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiac arrhythmias. Drugs. 1990 May;39(5):720-40. | ||||
Ref 528531 | Electrophysiologic properties of UK-66,914, a novel class III antiarrhythmic agent. J Cardiovasc Pharmacol. 1991 Mar;17(3):376-85. | ||||
Ref 528942 | Ionic currents involved in vasodilating actions of E4080, a newly synthesized bradycardia-inducing agent, in dispersed smooth muscle cells of the rabbit portal vein. J Pharmacol Exp Ther. 1991 Dec;259(3):1396-403. | ||||
Ref 529231 | ICI 181,037: a novel eukalemic diuretic with antiarrhythmic activity. Jpn J Pharmacol. 1991 Nov;57(3):263-77. | ||||
Ref 530084 | KR-31378, a potassium-channel opener, induces the protection of retinal ganglion cells in rat retinal ischemic models. J Pharmacol Sci. 2009 Apr;109(4):511-7. | ||||
Ref 530230 | Synthesis and selective class III antiarrhythmic activity of novel N-heteroaralkyl-substituted 1-(aryloxy)-2-propanolamine and related propylamine derivatives. J Med Chem. 1991 Nov;34(11):3212-28. | ||||
Ref 531239 | Electrophysiological properties of HBI-3000: a new antiarrhythmic agent with multiple-channel blocking properties in human ventricular myocytes. J Cardiovasc Pharmacol. 2011 Jan;57(1):79-85. | ||||
Ref 531373 | The effects of potassium channel opener P1075 on the human saphenous vein and human internal mammary artery. J Cardiovasc Pharmacol. 2011 Jun;57(6):648-55. | ||||
Ref 531486 | Effects of pinacidil, RP 49356 and nicorandil on ATP-sensitive potassium channels in insulin-secreting cells. Br J Pharmacol. 1990 Mar;99(3):487-92. | ||||
Ref 531635 | Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 2012 Jan;40(Database issue):D1128-36. | ||||
Ref 531817 | Iptakalim: A novel multi-utility potassium channel opener. J Pharmacol Pharmacother. 2012 Jan;3(1):12-4. | ||||
Ref 532406 | Evaluation of the bronchodilator properties of Ro 31-6930, a novel potassium channel opener, in the guinea-pig. Br J Pharmacol. 1990 Jun;100(2):289-94. | ||||
Ref 532667 | Rapid slowing of the atrial fibrillatory rate after administration of AZD7009 predicts conversion of atrial fibrillation. J Electrocardiol. 2014 May-Jun;47(3):316-23. | ||||
Ref 532744 | Stimulation of large-conductance calcium-activated potassium channels inhibits neurogenic contraction of human bladder from patients with urinary symptoms and reverses acetic acid-induced bladder hyperactivity in rats. Eur J Pharmacol. 2014 Jul 15;735:68-76. | ||||
Ref 532768 | Effects of the selective KACh channel blocker NTC-801 on atrial fibrillation in a canine model of atrial tachypacing: comparison with class Ic and III drugs. J Cardiovasc Pharmacol. 2014 May;63(5):421-7. | ||||
Ref 533559 | Decrease in bradycardic effect of AQ-A 39 and alinidine in guinea-pig sinoatrial node depolarized by high external K+-concentration. Naunyn Schmiedebergs Arch Pharmacol. 1984 Dec;328(2):210-3. | ||||
Ref 533609 | Action of KC-399, a newly synthesized potassium channel opener, on mechanical activity and 86Rb efflux in rat aorta. J Cardiovasc Pharmacol. 1994 Feb;23(2):220-6. | ||||
Ref 533616 | Potassium channel opener, YM 934, inhibits neurogenic plasma leakage in guinea pig airways. Am J Respir Crit Care Med. 1994 Nov;150(5 Pt 1):1379-83. | ||||
Ref 533769 | Potassium channel-opening and vasorelaxant profiles of a novel compound YM099 in rat isolated portal vein and rabbit isolated aorta. Arch Int Pharmacodyn Ther. 1994 May-Jun;327(3):330-43. | ||||
Ref 533790 | Antihypertensive and cardiovascular effects of a new potassium channel opener, TCV-295, in rats and dogs. J Cardiovasc Pharmacol. 1994 Dec;24(6):929-36. | ||||
Ref 533839 | Therapeutic potential of potassium channel activators in coronary heart disease. Eur Heart J. 1994 Aug;15 Suppl C:82-8. | ||||
Ref 533844 | A possible mechanism of action of a new potassium channel opener, AL0671, on lipid metabolism in obese Zucker rats. J Pharmacol Exp Ther. 1994 Dec;271(3):1666-71. | ||||
Ref 533948 | Vasorelaxant action of Ki1769, a new pyridinecarboximidamide, in isolated porcine coronary artery. Eur J Pharmacol. 1993 Sep 14;241(2-3):177-81. | ||||
Ref 533977 | Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle. Br J Pharmacol. 1993 Nov;110(3):1165-71. | ||||
Ref 534028 | Comparison of the airways relaxant and hypotensive potencies of the potassium channel activators BRL 55834 and levcromakalim (BRL 38227) in vivo in guinea-pigs and rats. Br J Pharmacol. 1993 Aug;109(4):1133-9. | ||||
Ref 534059 | Syntheses and biological activities of potent potassium channel openers derived from (+/-)-2-oxo-1-pyridin-3-yl-cyclohexanecarbothioic acid methylamide: new potassium channel openers. J Med Chem. 1993 May 28;36(11):1604-12. | ||||
Ref 534178 | Pharmacokinetics and safety of a novel, long-acting, prodrug-type potassium channel opener, Y-27152, in healthy volunteers. J Clin Pharmacol. 1996 May;36(5):439-51. | ||||
Ref 534264 | The novel cardioprotective agent BMS-180448 activates a potassium conductance in cardiac and vascular smooth muscle. Naunyn Schmiedebergs Arch Pharmacol. 1996 Oct;354(4):444-51. | ||||
Ref 534284 | Modulation of the Ca(2+)-dependent K+ channel, hslo, by the substituted diphenylurea NS 1608, paxilline and internal Ca2+. Neuropharmacology. 1996;35(7):903-14. | ||||
Ref 534399 | Effects of K+ channel inhibitors and antagonists on NS-004 evoked relaxations in guinea-pig isolated trachea. Fundam Clin Pharmacol. 1997;11(1):78-82. | ||||
Ref 534585 | Cardioprotective effects of KR-30450, a novel K+(ATP) opener, and its major metabolite KR-30818 on isolated rat hearts. Jpn J Pharmacol. 1998 Jan;76(1):65-73. | ||||
Ref 534618 | Synthesis and antihypertensive activity of 4-(diazabicyclo[4.1.0]-heptenyloxy)benzopyran derivatives and their analogues. Chem Pharm Bull (Tokyo). 1998 Apr;46(4):602-9. | ||||
Ref 534834 | The new antiarrhythmic substance AWD 23-111 inhibits the delayed rectifier potassium current (IK) in guinea pig ventricular myocytes. Pharmazie. 1999 Jan;54(1):61-8. | ||||
Ref 544581 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000214) | ||||
Ref 545461 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003350) | ||||
Ref 545903 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005293) | ||||
Ref 545905 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005294) | ||||
Ref 546074 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006187) | ||||
Ref 547258 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014533) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.